PGEN vs PNR · rev $9.7M vs P/E 18, rev $4.18B
Precigen Inc (PGEN) versus Pentair PLC (PNR) — a side-by-side from cached financials, not a winner call.
Precigen Inc (PGEN) is a biotechnology company listed on US.
Pentair PLC (PNR) is a specialty industrial machinery company listed on NYSE.
Latest reported PGEN revenue for 2025-12-31 was $9.7M. Net income was -$250.6M. PGEN currently screens at market cap $419.2M.
Latest reported PNR revenue for 2025-12-31 was $4.18B. Net income was $653.8M. Revenue was up 2.3% from 2024-12-31 to 2025-12-31. PNR currently screens at market cap $11.86B and trailing P/E 18.4.
PGEN currently screens at market cap $419.2M. PNR currently screens at market cap $11.86B and trailing P/E 18.4.
Not investment advice. Open the PGEN and PNR stock pages for the full models.
Not investment advice.